KKR & Co. is exploring options including selling its controlling stake in India’s JB Chemicals & Pharmaceuticals Ltd. amid interest from potential buyers, according to people familiar with the matter.
The US private equity firm is looking to hire financial advisers to help evaluate a sale of its 53.8% stake in the Mumbai-based company, the people said, asking not to be identified as the matter is private. Other buyout firms and industry players have shown preliminary interest in buying KKR’s stake, the people said.
Shares of the company, which is known as JB Pharma, have climbed 68% in the past 12 months, valuing the firm at just over $3 billion.
Can’t stop reading? Read more
LGT Capital Partners takes minority stake in CVC-backed Teneo at $2.3bn valuation
LGT Capital Partners takes minority stake in CVC-backed Teneo at $2.3bn valuation LGT Capital...
BlueFive Capital lands sovereign backing from Bahrain’s Mumtalakat
BlueFive Capital lands sovereign backing from Bahrain’s Mumtalakat Bahrain’s sovereign wealth...
Green Arrow Capital to acquire De Agostini’s alternatives arm in portfolio reshuffle
Green Arrow Capital to acquire De Agostini’s alternatives arm in portfolio reshuffle Green Arrow...